scispace - formally typeset
G

Gareth J. Walker

Researcher at University of Exeter

Publications -  41
Citations -  1114

Gareth J. Walker is an academic researcher from University of Exeter. The author has contributed to research in topics: Inflammatory bowel disease & Medicine. The author has an hindex of 8, co-authored 33 publications receiving 594 citations. Previous affiliations of Gareth J. Walker include Bristol Royal Infirmary & University Hospitals Bristol NHS Foundation Trust.

Papers
More filters
Journal ArticleDOI

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, +160 more
TL;DR: Clinical and pharmacokinetic factors that predict primary non-response at week 14 after starting treatment, non-remission at week 54, and adverse events leading to drug withdrawal are identified.
Journal ArticleDOI

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease

Aleksejs Sazonovs, +159 more
- 07 Oct 2019 - 
TL;DR: In an observational study, a genome-wide significant association between HLA-DQA1*05 and the development of antibodies against anti-TNF agents is found and a randomized controlled biomarker trial is required to determine whether pretreatment testing for HLA*05 improves patient outcomes by helping physicians select anti- TNF and combination therapies.
Journal ArticleDOI

Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.

Gareth J. Walker, +56 more
- 26 Feb 2019 - 
TL;DR: The findings suggest that NUDT15 genotyping may be considered prior to initiation of thiopurine therapy; however, further study including additional validation in independent cohorts is required.
Journal ArticleDOI

Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's disease

TL;DR: Few studies have reported the systematic use of exclusive enteral nutrition in the perioperative setting, and the need for further studies is still to be determined.
Journal ArticleDOI

Massively parallel variant characterization identifies NUDT15 alleles associated with thiopurine toxicity

TL;DR: A massively parallel assay was developed to preemptively characterize 91.8% of all possible missense variants in NUDT15, providing a comprehensive reference of variant function and vastly improving the ability to implement pharmacogenetics-guided thiopurine treatment individualization.